Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Indivior

Deal Watch January 2018

Licence. 350. Addex Therapeutics/ Indivior. ADX71441, selective positive allosteric modulator (PAM) for addiction (pc).

FDA panel backs Indivior’s drug to fight opioid addiction

FDA panel backs Indivior’s drug to fight opioid addiction FDA panel backs Indivior’ s drug to fight opioid addiction. The former RB pharma unit hopes for sales in the $1bn region. ... Indivior is on course to bring a new drug to market to tackle painkiller addiction in the US, offsetting the risks to its

Indivior slumps as patent dispute rises US generic spectre

Indivior slumps as patent dispute rises US generic spectre Indivior slumps as patent dispute rises US generic spectre. The RB spin out will appeal against the ruling. ... UK drugmaker Indivior suffered a major setback last week after a US patent ruling undermined one of its key products.

Ashley Communications celebrates 20 years of medical communications

Ashley Communications celebrates 20 years of medical communications Among this number are big pharma firmsand Merck &Co, as well as UK-based Abbott Diagnostics, opioid addiction specialist Indivior, Tokyo-based Otsuka, detection and informatics specialist Perkin Elmer and Torax

Result pages: 1 | 2 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics